This page lists all the contributors to the public consultation who provided comments on the "Review of the Variations Regulation (co-decision part)". In total, 19 contributions were received. Many of them, in particular the ones from the industry, are the results of wider consultation.
Below are the public responses to the above-mentioned public consultation.
Industry (associations or individual companies)
- AESGP - Association of the European Self-Medication Industry
- APIC - Active Pharmaceutical Ingredients Committee
- BPI - German Pharmaceutical Industry Association / VFA - Verband Forschender Arzneimittelhersteller
- EFPIA - European Federation of Pharmaceutical Industries and Associations, including:
- EBE - European Biopharmaceutical Enterprises
- EVM - European Vaccine Manufacturers
- EGA - European Generic Medicines Association
- IFAH-Europe - International Federation for Animal Health - Europe
- IPFA - International Plasma Fractionation Association
- MSD - Merck Sharp & Dohme (Europe) Inc., an affiliate of Merck & Co., Inc. (USA)
- PhRMA - The Pharmaceutical Research and Manufacturers of America
- Norgine - Individual European pharmaceutical company
National regulatory authorities
- AFMPS - Belgian Federal Agency for Medicines and HealthCare products
- AGES - Austrian Agency for Health and Food Safety
- French Ministry of Health (France)
- AFSSAPS - Agence Française de Sécurité Sanitaire des Produits de Santé (France)
- Malta - Ministry Of Health, The Elderly And Community Care
- Medicines Evaluation Board (the Netherlands)
- MHRA Medicines and Healthcare Products Regulatory Agency (UK)
Other stakeholders
- HAI - Health Action International Europe
- The Medicines in Europe Forum and The International Society of Drug Bulletins (joint contribution)